Publications found:
250,659
Sort by:
Breast Cancer Market– An Analysis
US$ 800.00
... US and Europe. Breast cancer market is comprised of two segments - diagnostic and therapy. The key drivers of breast cancer market are aging population, ... therapy or both are used. The major players of breast cancer market are strengthening their networks through international alliances, agreements, strategic ...
January 2010
39 pages
Analysis of Telemedicine Market
US$ 800.00
... rate and increasing health expenditure in emerging economies. However, the telemedicine market is also facing challenges like reimbursement by third party payers, ... the major market players with a discussion of their key business strategies. By combining SPSS Inc.’s data integration and analysis capabilities ...
January 2010
40 pages
Home Healthcare Market (2009-2014)
US$ 5,650.00
... years. Market Estimates and Forecast The report provides in-depth market estimates and forecasts for the global home healthcare market as follows: • Home Healthcare Equipment - Home therapeutic equipment (oxygen delivery systems, CPAP, nebulizers, ventilators, humidifiers, IV diagnostics, home dialysis, ostomy supplies, and others) - Home ...
January 2010
300 pages
Global Dental Consumables Market
US$ 5,650.00
... dental hand pieces, dental preventives, endodontics, and infection control products. This report provides an extensive analysis of the global dental consumables market, including current market size, market forecasts, market trend analysis, as well as a competitive analysis of the recent developments in the dental consumables market. The report also ...
January 2010
195 pages
Competitor Analysis: PSMA & PSA Targeted Therapy
US$ 180.00
... targeted therapy of prostate and other cancers. Prostate-specific antigen (PSA) was discovered more than 20 years ago and has become the ... PSA Targeted Therapy Corporate PSMA & PSA Targeted Therapy R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers ...
January 2010
18 pages
Competitor Analysis: Selective Estrogen Receptor Modulators
US$ 180.00
... Indication, R&D Stage and additional comments with a hyperlink leading to the source of information. Index Selective Estrogen Receptor Modulators Corporate SERM R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
January 2010
19 pages
U.S. Market for PACS and EMR 2010
US$ 7,495.00
... PACS was valued at almost $1.3 billion, representing an increase of 6.7% over 2007. This market encompasses large hospitals (500+ beds), medium hospitals (201-499 beds), ... ). This growth will be fuelled by the sales of PACS, mostly to the community and imaging center markets. Replacement–driven sales will fuel ...
December 2009
217 pages
Research Report of China Vitamin Complex Market
US$ 400.00
Vitamin complex enjoys a global market of tens of billions of dollars. For China, a nation who makes up one-fifth of the world’s population, the application amount of vitamin complex remains only one-...
December 2009
11 pages
Global Dental Industry: An Analysis
US$ 800.00
... have also impacted the growth of the industry positively. The main driving element for global dental equipment market is the advancement in technologies ... with 20% of market share. The report focuses on various aspects of dental industry including the market size and geographical segmentation of the market ...
December 2009
41 pages
US Home Healthcare Equipment & Services Market: An Analysis
US$ 800.00
... demand for home healthcare services, thereby leading to an increase in the number of home healthcare agencies in the country. The home healthcare equipment and services ... . The report titled “Aging Population Driving the US Home Healthcare Equipment & Service Market” analyzes the different segments of the ...
December 2009
38 pages
Competitor Analysis: Neurotrophic Growth Factors
US$ 480.00
... disease Alzheimer's disease Multiple sclerosis Huntington's disease Ophthalmic diseases Various Corporate Neurotrophic Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of ...
December 2009
38 pages
Competitor Analysis: Growth Factors for Bone, Dental, Cartilage and Tendon Repair
US$ 360.00
... engineered peptides, antibodies, small molecules or even plasmids. Among the growth stimulators are the BMPs, GDFs, PDGF, PTH receptor agonists, ... , Dental, Cartilage and Tendon Growth Factor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS ...
December 2009
42 pages
Competitor Analysis: Tissue Growth Factors
US$ 960.00
... description The present Competitive Intelligence Report about tissue growth factors provides a competitor evaluation in the field of molecules such as proteins, peptides ... as HGF, VEGF, TGF, NGF, GDF and quite a number of neurotrophic factors are under development. Apart from proteins as the classical drugs ...
December 2009
57 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 216.00
Product description The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TG...
November 2009
20 pages
Pharma & Social Media -- Report Collection
US$ 975.00
1.7 billion users
More than 380 per cent growth since 2000
Nearly 75 per cent penetration in North America alone1
The fastest growing, most complex, yet easiest-to-access...
November 2009
161 pages
The Roche Intelligence Dossier
US$ 295.00
As the fourth largest pharmaceutical company in the world, with annual revenues of $43.9 billion, some of the most instantly recognisable drugs marketed and the kind of pipeline smaller companies only...
November 2009
48 pages
The GSK Intelligence Dossier
US$ 295.00
After two anemic years, GSK is ready to breathe new life.Despite intense competition from generics in the US, the company has finally reported a healthy growth in the third quarter of 2009.Now, eager...
November 2009
53 pages
The Novartis Intelligence Dossier
US$ 295.00
International censure over Novartis’ grave delays in supplying the H1N1 vaccine.Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power.A...
November 2009
55 pages
The Value of a Good Reputation in Pharma
US$ 795.00
“It takes many good deeds to build a good reputation,” Benjamin Franklin once wisely observed, “and only one bad one to lose it.”How many good deeds will it take to repair the pharmaceutical industry’...
November 2009
40 pages
Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009 (3 Countries)
US$ 8,495.00
... includes Japan, South Korea, and Australia. In 2008, the combined Asia-Pacific market for dental bone graft substitutes (BGS) and other biomaterials was ... account for an unusually large percentage of dental BGS materials used in the Asia-Pacific region because allograft and xenograft products are not approved ...
November 2009
200 pages
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
US$ 5,650.00
... and forecast This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the ... positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. - Comprehensive market analysis for the following sectors: ...
November 2009
126 pages
Global Stem Cell and Advanced Technologies Market
US$ 5,650.00
... the global stem cell market as follows: • Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types) • Stem Cell Services (stem cell banking, stem cell ... and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We ...
November 2009
229 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 360.00
Product description The present Competitive Intelligence Report about FGF-R agonists and antagonists provides a competitor evaluation in the field of fibroblast growth factor receptor (FGF-R) or PDGF targeting molecules for wound healing, cardiac tissue repair, bone formation or treatment of cancer as of ...
November 2009
37 pages
Competitor Analysis: Proteasome Inhibitors
US$ 120.00
... R&D Stage and additional comments with a hyperlink leading to the source of information. Index Velcade Pipeline Proteasome Inhibitors Corporate Proteasome Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
November 2009
14 pages
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
US$ 360.00
... The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor ... approved and marketed drug is plerixafor (AMD3100), a small molecule inhibitor of the CXCR-4/SDF-1 axis, used for stem cell mobilization. CXCR1 and ...
November 2009
30 pages
Veterinary Diagnostics Markets
US$ 995.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogeni...
October 2009
30 pages
Conference Intelligence Dossier: EASD Annual Meeting 2009
US$ 995.00
The numbers are staggering: More than 200 million people around the world now suffer from diabetes and its major complications. According to the World Health Organization, that figure is expected to s...
October 2009
90 pages
The Pfizer Intelligence Dossier
US$ 295.00
In boardrooms, around water coolers and behind closed office doors, decision-makers in the pharmaceutical industry are asking questions: What’s happening with Pfizer? What developments have occurred i...
October 2009
60 pages
Pharma Sales Forces: Change in the Face of Adversity
US$ 395.00
“Change,” futurist Alvin Toffler once said, “is the process by which the future invades our lives.” For the pharmaceutical sales industry, that future is unfolding now. Dropping revenue, increasingly...
October 2009
40 pages
European Markets for Interventional Cardiology 2009 (15 Countries)
US$ 11,495.00
... 2008, the European market for interventional cardiology was valued at over €1.5 billion. The interventional cardiology market includes drug-eluting stents, ... devices, and IVUS catheters. In addition, this report covers the emerging markets for optical coherence tomography (OCT), vulnerable plaque screening, PFO ...
October 2009
409 pages
Japanese Market for Women's Health Devices 2009
US$ 7,495.00
... for women’s health devices was valued at over $234 million. Over 40% of the Japanese market for women’s health devices was accounted for by OB/GYN ultrasound imaging alone. The market for women’s health includes the segments and sub-segments for bone densitometry, breast biopsy, ...
October 2009
250 pages
